Stoke Therapeutics (STOK) Other Non Operating Income (2022 - 2025)
Historic Other Non Operating Income for Stoke Therapeutics (STOK) over the last 4 years, with Q3 2025 value amounting to $3000.0.
- Stoke Therapeutics' Other Non Operating Income fell 8928.57% to $3000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $260000.0, marking a year-over-year increase of 16388.21%. This contributed to the annual value of -$247000.0 for FY2024, which is 24879.52% down from last year.
- Stoke Therapeutics' Other Non Operating Income amounted to $3000.0 in Q3 2025, which was down 8928.57% from $28000.0 recorded in Q2 2025.
- In the past 5 years, Stoke Therapeutics' Other Non Operating Income registered a high of $201000.0 during Q4 2024, and its lowest value of -$428000.0 during Q1 2024.
- Over the past 4 years, Stoke Therapeutics' median Other Non Operating Income value was $41000.0 (recorded in 2023), while the average stood at $9666.7.
- Data for Stoke Therapeutics' Other Non Operating Income shows a peak YoY increase of 39024.39% (in 2024) and a maximum YoY decrease of 111904.76% (in 2024) over the last 5 years.
- Quarter analysis of 4 years shows Stoke Therapeutics' Other Non Operating Income stood at $42000.0 in 2022, then fell by 2.38% to $41000.0 in 2023, then skyrocketed by 390.24% to $201000.0 in 2024, then plummeted by 98.51% to $3000.0 in 2025.
- Its Other Non Operating Income stands at $3000.0 for Q3 2025, versus $28000.0 for Q2 2025 and $28000.0 for Q1 2025.